New product intros (amikacin liposome inhalation suspension (new formulation), anagliptin/metformin hydrochloride (new combination), fruquintinib, gilteritinib, Inotersen, larotrectinib sulfate (first-in-class), lorlatinib, moxetumomab pasudotox-tdfk, omidenepag isopropyl, vibegron)
Keyword(s):
Keyword(s):
Keyword(s):
Keyword(s):